Sorry, you need to enable JavaScript to visit this website.
주요 콘텐츠로 건너뛰기
LOCATION

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

뉴질랜드

  • Advanced medical and research infrastructure
  • Simple and fast regulatory pathways

 
Importantly, New Zealand also offer alternative recruitment potential to northern hemisphere seasonally related studies.

Recently the activity growth of biotechnology companies in New Zealand grew about +18%, with oncology, neurology and infectious diseases representing about half of the clinical activity.

Novotech has built strong expertise over the years in providing CRO services to biotechnology companies in New Zealand.
 
New Zealand has a prestigious reputation in medical research, producing internationally acclaimed researchers and innovations. The country has 8 teaching and research hospitals and the population is centered around regional and urban cities.

Clinical trials are run by internationally accepted GCP standards and monitored by HDEC and Medsafe bodies. New Zealand offers fast trial reviews within 35 days or 15 days for expedited reviews.